Rasagiline mesylate and Speech disorder - a phase IV clinical study of FDA data
We study 638 people who have side effects when taking Rasagiline mesylate. Speech disorder is found, especially among people who are male, 60+ old, also take Nuplazid and have Parkinson's disease.
The phase IV clinical study analyzes which people take Rasagiline mesylate and have Speech disorder. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
638 people reported to have side effects when taking Rasagiline mesylate.
Among them, 18 people (2.82%) have Speech disorder.
What is Rasagiline mesylate?
Rasagiline mesylate has active ingredients of rasagiline mesylate. Currently, eHealthMe is studying from 661 Rasagiline mesylate users.
What is Speech disorder?
Speech disorder is found to be associated with 2,561 drugs and 2,242 conditions by eHealthMe. Currently, we are studying 59,483 people who have Speech disorder.
Number of Rasagiline mesylate and Speech disorder reports submitted per year:
Gender of people who have Speech disorder when taking Rasagiline mesylate*:
Age of people who have Speech disorder when taking Rasagiline mesylate *:
Common drugs people take besides Rasagiline mesylate *:
Common side effects people have besides Speech disorder *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Rasagiline mesylate and have Speech disorder?Check whether Speech disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
Rasagiline mesylate side effects by duration, gender and age:
- Rasagiline mesylate side effects (661 reports)
Speech disorder treatments and more:
- Speech disorder (59,483 reports)
Common drugs associated with Speech disorder:
- Aspirin: 2,518 reports
- Lyrica: 2,413 reports
- Tysabri: 1,923 reports
- Prednisone: 1,792 reports
- Omeprazole: 1,693 reports
- Gabapentin: 1,640 reports
- Avonex: 1,504 reports
- Metformin: 1,491 reports
- Lorazepam: 1,380 reports
- Clonazepam: 1,372 reports
All the drugs that are associated with Speech disorder:
- Speech disorder (2,561 drugs)
Common conditions associated with Speech disorder:
- Multiple sclerosis: 5,908 reports
- High blood pressure: 2,700 reports
- Depression: 2,545 reports
- Pain: 2,242 reports
- Parkinson's disease: 2,074 reports
- Rheumatoid arthritis: 1,500 reports
All the conditions that are associated with Speech disorder:
- Speech disorder (2,242 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rasagiline mesylate (the active ingredients of Rasagiline mesylate) and Rasagiline mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cefuroxime Axetil and Pepcid Complete drug interaction - 16 seconds ago
- Melatonin and Clofibrate drug interaction - 43 seconds ago
- Ginger and Ibuprofen drug interaction - 55 seconds ago
- Januvia and Magnesium Sulfate drug interaction - a minute ago
- Meloxicam and Blood Glucose Increased - a minute ago
- Betamethasone Valerate and Lamisil drug interaction - a minute ago
- Oncaspar and Depression - a minute ago
- Glipizide and Generalized Anxiety Disorder - 2 minutes ago
- Irbesartan and Skin Atrophy - 3 minutes ago
- Capecitabine and Cimetidine drug interaction - 3 minutes ago